Patent
Brisc deubiquitinating enzyme inhibitors
06 Jun 2024
Abstract
The present disclosure provides for techniques using BRISC deubiquitinating enzyme inhibitors of formula (I) for treating and/ or preventing systemic lupus erythematosus (SLE). Accordingly, the present disclosure provides for compositions and methods for treating or preventing a disease or disorder mediated by inhibition of type I interferon receptor (IFNAR1) signaling.
Metrics
1 Record Views
Details
- Title
- Brisc deubiquitinating enzyme inhibitors
- Creators
- Elton ZeqirajFrank SicheriRoger GreenbergJoseph M Salvino - Drexel University
- Resource Type
- Patent
- Language
- English; French
- Patent
- WO2024115713A1; A1
- Academic Unit
- Pharmacology and Physiology
- Identifiers
- 991021904614304721